- Confronting the Care Delivery Challenges Arising from Precision Medicine
Elise C. Kohn et al, 2016, Front. Oncol. CrossRef - p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers.
Eric J Devor et al, 2017, Int J Oncol CrossRef - Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer
Moito Iijima et al, 2017 CrossRef - Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells
Ugo Testa et al, 2018, Medicines CrossRef - Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS)
Marica Garziera et al, 2018, IJMS CrossRef - Clinical Outcomes of TP53 Mutations in Cancers
Ana I. Robles et al, 2016, Cold Spring Harb Perspect Med CrossRef - TP53 Mutations in Breast and Ovarian Cancer
Laxmi Silwal-Pandit et al, 2017, Cold Spring Harb Perspect Med CrossRef - Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors
S. Y. Cindy Yang et al, 2018, Genome Med CrossRef - Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations
Xiangbing Meng et al, 2018, Disease Markers CrossRef - TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses
Victoria Mandilaras et al, 2019, Int J Gynecol Cancer CrossRef - Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer
Megan McDonald et al, 2019, IJMS CrossRef - Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers
Katharina Bischof et al, 2019, Sci Rep CrossRef - New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach
Marica Garziera et al, 2019, Cells CrossRef - TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer
Hung-Chih Hsu et al, 2019, Cancers CrossRef - TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas
Brandon-Luke L. Seagle et al, 2015, Gynecologic Oncology CrossRef - Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments
Yaoqing Shen et al, 2019, Proc Natl Acad Sci USA CrossRef - Capture-based next-generation sequencing reveals multiple actionable mutations in cancer patients failed in traditional testing
Jing Xie et al, 2016, Mol Genet Genomic Med CrossRef - The association between codon72 polymorphism of p53 gene and the risk of endometrial cancer: an updating meta-analysis
Xinzi Lin et al, 2016, Arch Gynecol Obstet CrossRef - Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer
Åsa Fransson et al, 2016, J Ovarian Res CrossRef - Molecular diagnosis and molecular profiling to detect treatment-resistant ovarian cancer
Diana P. English et al, 2016, Expert Review of Molecular Diagnostics CrossRef - Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives
Alka Singh et al, 2019, Front. Cell Dev. Biol. CrossRef - Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma
Wei Dai et al, 2017, J. Pathol CrossRef - Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53
Yajie Chen et al, 2019, Cell Death Dis CrossRef - Immunohistochemical expression of p53 in Type I and II epithelial ovarian cancer among Sudanese women: a cross-sectional study
Aisha Osman Mohamed et al, 2019, F1000Res CrossRef - Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)
Marica Garziera et al, 2019, Cells CrossRef - Variable Mutations at the p53-R273 Oncogenic Hotspot Position Leads to Altered Properties
Ankush Garg et al, 2019, Biophysical Journal CrossRef - Characterization of a TP53 Somatic Variant of Unknown Function From an Ovarian Cancer Patient Using Organoid Culture and Computational Modeling.
Jianling Bi et al, 2020, Clin Obstet Gynecol CrossRef - Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab
Chi-Wei Tao et al, 2020, Case Reports in Oncological Medicine CrossRef - Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers
Brandon-Luke L. Seagle et al, 2015, Oncotarget CrossRef - Spectrum of TP53 Mutations in BRCA1/2 Associated High-Grade Serous Ovarian Cancer.
Ulyana A Boyarskikh et al, 2020, Front Oncol CrossRef - Insight updating of the molecular hallmarks in ovarian carcinoma
Alba Mota et al, 2020, European Journal of Cancer Supplements CrossRef - Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations
Talayeh S. Ghezelayagh et al, 2020, Gynecologic Oncology CrossRef - A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients
Yingli Zhang et al, 2021, Sci Rep CrossRef - Small Non-Coding-RNA in Gynecological Malignancies
Shailendra Kumar Dhar Dwivedi et al, 2021, Cancers CrossRef - Mechanisms of High-Grade Serous Carcinogenesis in the Fallopian Tube and Ovary: Current Hypotheses, Etiologic Factors, and Molecular Alterations
Isao Otsuka, 2021, IJMS CrossRef - Mutated p53 in HGSC—From a Common Mutation to a Target for Therapy
Aya Saleh et al, 2021, Cancers CrossRef - Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor
Zih-Yin Lai et al, 2021, IJMS CrossRef - null
Khalid El Bairi et al, 2021 CrossRef